Inspire Medical Systems, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INSP research report →
Companywww.inspiresleep.com
Inspire Medical Systems, Inc. , a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
- CEO
- Timothy Herbert
- IPO
- 2018
- Employees
- 1,246
- HQ
- Golden Valley, MN, US
Price Chart
Valuation
- Market Cap
- $1.27B
- P/E
- 9.66
- P/S
- 1.39
- P/B
- 1.60
- EV/EBITDA
- 16.64
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 85.78%
- Op Margin
- 5.61%
- Net Margin
- 14.33%
- ROE
- 17.98%
- ROIC
- 6.24%
Growth & Income
- Revenue
- $911.98M · 13.60%
- Net Income
- $145.42M · 171.77%
- EPS
- $4.95 · 175.00%
- Op Income
- $50.95M
- FCF YoY
- -13.88%
Performance & Tape
- 52W High
- $149.71
- 52W Low
- $39.61
- 50D MA
- $52.49
- 200D MA
- $78.22
- Beta
- 0.83
- Avg Volume
- 1.18M
Get TickerSpark's AI analysis on INSP
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Rondoni John | sell | 2,641 |
| May 14, 26 | Rondoni John | sell | 700 |
| May 8, 26 | mcCormick Shawn | sell | 696 |
| Apr 30, 26 | Ellis Gary Lee | other | 3,562 |
| Apr 30, 26 | Mead Dana G Jr. | other | 3,562 |
| Apr 30, 26 | Tansey Casey M | other | 3,562 |
| Apr 30, 26 | Curet Myriam | other | 3,562 |
| Apr 30, 26 | Burks Cynthia | other | 3,562 |
| Apr 30, 26 | Broader Shelley G | other | 3,562 |
| Apr 30, 26 | mcCormick Shawn | other | 3,562 |
Our INSP Coverage
We haven't published any research on INSP yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate INSP Report →